Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts
Scientific News
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Fighting the Colorado Potato Beetle with RNA
RNA interference protects potato plants against herbivore attack.
Acetate Supplements Shown to Speed Up Cancer Growth
A major compound produced in the gut by host bacteria.
Two Cell-Signaling Molecules Found to Suppress the Spread of Melanoma
Findings advance efforts to identify who would benefit from more aggressive therapy at earliest stages.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
Researchers Identify ‘Achilles heel’ in Metabolic Pathway
Achilles heel could lead to new lung cancer treatments.
New Resource to Study the Mechanism and Regulation of Autophagy
New online resource will provide an integrated and systems-level database for autophagy research.
Researchers Discover Possible Mechanism for Faster Evolution
Results hold great promise for gene therapy development.
Return
DNA Methylation and the Cancer Epigenome Biological and Translations Implications
Stephen Baylin, Johns Hopkins University School of Medicine, speaking at Genomics Research Europe 2012
Date Posted: Wednesday, January 01, 2014
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Johns Hopkins Scientists Use Pap Test Fluid To Detect Ovarian, Endometrial Cancers
In a pilot study, the “PapGene” test, which relies on genomic sequencing of cancer-specific mutations, accurately detected 100 percentof endometrial cancers and (41 percent ovarian cancers.
Monday, January 14, 2013
 
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters